Skin cancer is one of the most common forms of cancer globally, and when it occurs on the head or neck, it can be particularly concerning. If you've been diagnosed with basal cell carcinoma or squamous cell carcinoma in these areas, by a Dermatologist, request a referral to The ENT Center of Excellence in Redding, CA, led by the expertise of Dr. Bergstrom and Dr. Buxa, they offer state-of-the-art care for head and neck skin cancer patients, utilizing advanced skin substitutes and wound closure techniques.
April is Head & Neck Cancer Month – let’s get a start on it!
Sometimes, after a skin cancer lesion is surgically removed, the integrity of the skin needs to be restored. For larger or more complex wounds, skin substitutes play a critical role in healing and restoring function. Dr. Bergstrom and Dr. Buxa will carefully assess your condition and recommend the best approach to wound closure and healing. The use of advanced materials such as EPIFIX, EPIEFFECT, Restorigin™, and Puraply stems from their dedication to providing exceptional care and achieving optimal outcomes for their patients.
Skin Substitutes for Healing
Skin substitutes offer significant advantages in the treatment of complex skin conditions such as those resulting from head and neck cancer excisions. By aligning with the body's natural healing processes, these advanced materials act as templates for tissue regeneration, promoting faster wound closure and minimizing scar formation. They have been pivotal in reducing the risk of infection and improving aesthetic outcomes, which is particularly important for areas of the body that are visible and prone to movement.
Furthermore, the ease of integration of these substitutes into the patient's existing tissue has ushered in an era of reduced procedural times, less patient discomfort, and quicker recovery periods, which add to their ever-growing appeal in modern surgical practices.
EPIFIX: A Barrier for Healing
EPIFIX is an innovative solution to promote wound healing. As a dehydrated human amnion/chorion membrane (DHACM) allograft, it provides a barrier to protect the wound bed and facilitate the growth of new tissue. The following points highlight EPIFIX's utility and assurance of quality:
Derived from donated placental tissue from healthy live births in the US.
Preserves essential components of the extracellular matrix, including various proteins and regulatory factors.
EPIEFFECT: A Triple Layer of Protection
EPIEFFECT is another form of lyophilized human placental-based allograft that encompasses the amnion, intermediate, and chorion layers. Its characteristics make it suitable for acute and chronic wounds:
Acts as a robust barrier for the wound environment.
Sourced from healthy, consenting donors following a Caesarean section.
Restorigin™: Amniotic Flexibility in Wound Management
Restorigin™ is unique in that it is a dual-layer amniotic membrane beneficial for its protective barrier characteristics in wound care. The product has noteworthy features that include:
A natural adhesive quality to the patient's tissue without the need for sutures.
Growth factor support for managing both acute and chronic wounds.
Puraply: Reinforcing Wound Healing
For wounds left by the removal of skin cancer, Puraply presents an advantageous native, cross-linked extracellular matrix scaffold. It is distinguished by:
Antimicrobial attributes within the product to aid in granulation tissue formation.
Noteworthy efficacy shown in the RESPOND study, revealing improvement in wound bed conditions in 86% of cases and complete closure in 41.5% of wounds within 12 weeks.
ENT Center of Excellence uses these innovative wound treatments following large skin cancer removal from the head and neck to provide the highest level of recovery and enhance your healing. Experience the compassionate and expert care at ENT Center of Excellence.
For more information, ask your Dermatologist for a referral to the ENT Center of Excellence. Your health and well-being is their top priority and they’re here to support every step of your recovery.